• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Current Problems in Cardiology

    Current Problems in Cardiology

    JournalISSN 0146-2806eISSN 1535-6280中科院 医学 3区

    年发文量

    研究主题

    论文(2718)

    排序
    1NewHypertension among Civil Servants: a Cross-Sectional Study in Osun State, Nigeria
    PM Olagunju, MM Igbodipe, BO Ojeyinka, BO Olatona, AT Adedeji, CA Akinleye

    Background Hypertension is a major public health concern associated with cardiovascular complications, including heart disease and stroke. This study assessed hypertension knowledge, prevalence, and associated risk factors among civil servants in Osun State, Nigeria. Methods A cross-sectional study was conducted among 305 civil servants selected through multistage sampling. Data were collected using a semi-structured questionnaire and analysed using SPSS version 23. Binary logistic regression examined predictors of hypertension knowledge and selected modifiable risk behaviours. Statistical significance was set at p < 0.05. Results Participants’ mean age was 39.48 ± 7.50 years. Overall, 75.7% had good knowledge of hypertension, while the observed hypertension prevalence was 44.6%. Participants aged 20–39 years had higher odds of good knowledge than those aged 40–59 years (AOR=1.74, 95% CI: 1.02–2.96). Males had higher odds of smoking (AOR=13.58, 95% CI: 1.78–103.64) and alcohol consumption (AOR=3.99, 95% CI: 2.08–7.65). Monogamous respondents had lower odds of alcohol consumption than polygamous respondents (AOR=0.40, 95% CI: 0.20–0.80). Younger age was associated with the physical activity outcome (AOR=0.35, 95% CI: 0.18–0.70). Conclusion Despite good hypertension knowledge, the observed prevalence was substantial. Workplace interventions should extend beyond health education to integrating blood pressure screening, early referral, appropriate management, targeted lifestyle modification. Collaboration between government agencies and occupational health services is essential for implementing sustainable cardiovascular health programmes.

    2027
    引用
    AI阅读
    加入学术空间
    2NewIntravascular Lithotripsy Versus Rotational Atherectomy for Calcified Coronary Lesions: an Updated Meta-Analysis of Randomized Controlled Trials
    Robert Willian Anastácio Alcântara,Vinícius Martins Rodrigues Oliveira, Marco Tagliafierro,Paulo Roberto Ferreira Tartuce Filho, Ludimilla Pereira Tartuce, Cleverson Zukowski,Ignacio J. Amat-Santos

    Introduction Intravascular lithotripsy (IVL) and rotational atherectomy (RA) are widely used for plaque modification in calcified coronary lesions, but head-to-head randomized evidence is limited. Prior meta-analyses, based mainly on observational data, suggested an early benefit with IVL. We performed an updated meta-analysis restricted to randomized controlled trials (RCTs). Methods PubMed, Embase and the Cochrane Library were searched through September 2026 for RCTs comparing IVL with RA before stenting of moderately to severely calcified coronary lesions. The primary outcome was major adverse cardiac events (MACE) at 12 months. Binary outcomes were pooled as Peto odds ratios (ORs) with 95% confidence intervals (CIs). Risk of bias was assessed with RoB 2.0 and certainty of evidence with GRADE. Results Four RCTs including 394 patients (193 IVL, 201 RA) were included. MACE did not differ between strategies (OR 1.42, 95% CI 0.56–3.61; I²=0%). No differences were observed in cardiac death (OR 0.52, 95% CI 0.05–5.06), all-cause death (OR 0.77, 95% CI 0.22–2.62), myocardial infarction (MI) (OR 2.76, 95% CI 0.39–19.65), periprocedural MI (OR 0.67, 95% CI 0.01–31.58), target lesion failure (OR 2.76, 95% CI 0.81–9.49), target lesion revascularization (OR 2.69, 95% CI 0.79–9.09) or procedural success (OR 0.46, 95% CI 0.14–1.50). Certainty of evidence was low for all outcomes. Conclusions In randomized evidence, IVL and RA yielded comparable clinical outcomes in calcified coronary lesions eligible for both strategies. Given the small number of trials and sparse events, these findings should be considered hypothesis-generating.

    2027
    引用
    AI阅读
    加入学术空间
    3NewTrends and Disparities in Mortality Related to Cardiac Arrest and Cardiogenic Shock: A 1999–2024 United States Analysis
    Hritvik Jain,Muhammad Rafay Shahzad Cheema,Kriti Soni,Mitchel A Sklar, Marwan S Saad,J Dawn Abbott,Saraschandra Vallabhajosyula

    Cardiac arrest (CA) complicating cardiogenic shock (CS) identifies a high-risk phenotype, but population-level mortality trends among patients with both conditions are not well described. Using the CDC WONDER Multiple Cause of Death database, we identified deaths among US adults aged ≥25 years from 1999 to 2024 in which both CA (ICD-10 I46) and CS (R57.0) were recorded on the same death certificate and compared them with all CS-related deaths. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated, and temporal trends were assessed using Joinpoint regression. Overall, 98,531 CA+CS deaths occurred, compared with 577,658 CS-related deaths. The AAMR for CA+CS declined from 1.3 in 1999 to 0.9 in the mid-2000s, rose by 10.1% per year between 2009 and 2021 (95% CI 9.8 to 10.5) to a peak of 2.9, and declined modestly to 2.7 by 2024. The share of CS deaths that also listed CA increased from 12.4% to 18.9%. Men had consistently higher AAMRs than women (3.6 vs 1.9 in 2024), and adults aged ≥65 years accounted for 71.3% of deaths. Non-Hispanic Black adults had the highest rates from 2016 onward and the steepest increase, while the West had the highest and the Midwest the lowest rates among census regions. CA+CS mortality in the United States has roughly doubled since 1999, with persistent differences by sex, race and ethnicity, age, and region that warrant study with clinically detailed data.

    2027
    引用
    AI阅读
    加入学术空间
    4NewMemory and Forgetting in Avicenna’s Thought: A Philosophical–medical Perspective on Alzheimer’s Disease
    Farah Ramin
    2027
    引用
    AI阅读
    加入学术空间
    5NewNational Trends, Disparities, and Inpatient Outcomes of Cardiac Amyloidosis Hospitalizations in the United States During the Era of Disease-Modifying Therapy
    Hanzala Ahmed Farooqi,Bakhtawara Alam, Taimor Mohammed Khan, Aabia Talhaa, Ayesha Haider, Hafiz Muhammad Umar Hayat, Şakir Hicazi, Hira Fatima, Farhan Babar

    Background Tafamidis, approved in 2019, was the first disease-modifying therapy for transthyretin amyloid cardiomyopathy. Disparities in cardiac amyloidosis outcomes remain incompletely characterized. Objectives To characterize US trends in cardiac amyloidosis hospitalizations, subtypes, and risk-adjusted mortality from 2017 to 2022, including changes around tafamidis approval. Methods We analyzed the 2017-2022 National Inpatient Sample, defining cases by an amyloidosis code (E85.x) paired with a heart failure or restrictive cardiomyopathy code. Survey-weighted regression assessed outcomes; Joinpoint and segmented regression tested for a 2019 trend inflection. Results Of an estimated 111,450 hospitalizations, 83 % were coded as Other/Unspecified amyloidosis. In-hospital mortality was 7.1 %, highest in light-chain (AL) amyloidosis (9.4 %) and lowest in wild-type transthyretin amyloidosis (4.9 %; adjusted odds ratio 0.48 vs AL). The age-standardized hospitalization rate nearly doubled, from 4.2 to 8.0 per 100,000 adults, with no inflection detected at 2019. Private and “Other” payer status were associated with higher adjusted mortality than Medicare, the mortality difference for uninsured patients increased over time, and Black patients had lower adjusted odds of pacemaker implantation. Black patients accounted for a larger share of hereditary ATTR admissions than of other subtypes in every year. Conclusions Cardiac amyloidosis hospitalizations rose steadily from 2017 to 2022, and no inflection was detected at the 2019 approval of tafamidis. Because the NIS lacks data on treatment exposure, diagnostic testing, and disease severity, these findings cannot establish whether tafamidis influenced hospitalization trends. Differences in in-hospital mortality by payer and in pacemaker implantation by race persisted and warrant investigation with patient-level clinical data.

    2027
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2718 篇论文

    高被引作者

    作者引用发文
    Paul M. Ridker30132
    Amer Harky21589
    Barry A. Franklin20941
    C. Arden Pope III20941
    Robert Brook20941
    Irwin Klein18501
    Sara Danzi18501
    Sevim Zaim18412
    Vissagan Sankaranarayanan18412
    Jun Heng Chong18412

    高产作者

    作者引用发文
    Rami N Khouzam54252
    Carl Lavie164552
    Dhrubajyoti Bandyopadhyay42835
    Guillermo Cueto-Robledo19832
    Shahbudin Rahimtoola84831
    Ernesto Roldan-Valadez24528
    Ross Arena66628
    Shahid Ullah Khan40727
    Abdul Mannan Khan Minhas16026
    Adrija Hajra26524

    相关期刊

    Acta cardiologica
    Cardiology
    International Journal of Cardiology
    Current Cardiology Reports
    Reviews in cardiovascular medicine
    Future cardiology
    Canadian Journal of Cardiology
    American Journal of Cardiology
    Trends in Cardiovascular Medicine
    Clinical Research in Cardiology